NDC properties for NDC 9 0597-0149
NDC item 00597014954
| NDC 9 | 0597-0149 |
|---|---|
| NDC 10 | 0597-0149-54 |
| NDC Item | 00597014954 |
| packaging | 1 BOTTLE in 1 CARTON (0597-0149-54) / 60 CAPSULE in 1 BOTTLE |
| COLORTEXT | WHITE(Cream colored) |
| Color | C48325 __ |
| FDA SPL set id | 449337 |
| Imprint code | R75 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2020-06-08 |
| Marketing effective time low | 2011-08-08 |
| Marketing status | DROPPED |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 00597014960
| NDC 9 | 0597-0149 |
|---|---|
| NDC 10 | 0597-0149-60 |
| NDC Item | 00597014960 |
| packaging | 10 BLISTER PACK in 1 CARTON (0597-0149-60) / 6 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE(Cream colored) |
| Color | C48325 __ |
| FDA SPL set id | 449337 |
| Imprint code | R75 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2020-06-08 |
| Marketing effective time low | 2011-08-08 |
| Marketing status | DROPPED |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 00597035509
| NDC 9 | 0597-0355 |
|---|---|
| NDC 10 | 0597-0355-09 |
| NDC Item | 00597035509 |
| packaging | 1 BOTTLE in 1 CARTON (0597-0355-09) / 60 CAPSULE in 1 BOTTLE |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750257 |
| Imprint code | R75 |
| Labeler | Boehringer Ingelheim Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2011-08-08 |
| Marketing status | ACTIVE |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 00597035553
| NDC 9 | 0597-0355 |
|---|---|
| NDC 10 | 0597-0355-53 |
| NDC Item | 00597035553 |
| packaging | 12 BLISTER PACK in 1 CARTON (0597-0355-53) / 1 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750257 |
| Imprint code | R75 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2011-08-08 |
| Marketing status | ACTIVE |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 00597035556
| NDC 9 | 0597-0355 |
|---|---|
| NDC 10 | 0597-0355-56 |
| NDC Item | 00597035556 |
| packaging | 60 BLISTER PACK in 1 CARTON (0597-0355-56) / 1 CAPSULE in 1 BLISTER PACK |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750257 |
| Imprint code | R75 |
| Labeler | Boehringer Ingelheim Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2011-08-08 |
| Marketing status | ACTIVE |
| NDA | NDA022512 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |